Denub 60MG Injection (1ml) is a pharmaceutical product containing Denosumab, a monoclonal antibody that plays a crucial role in the treatment of various bone-related conditions. This injection is primarily used to manage osteoporosis in postmenopausal women and to prevent skeletal-related events in patients with bone metastases from solid tumors. Denub works by inhibiting the activity of osteoclasts, the cells responsible for bone resorption, thereby promoting bone density and strength. Each 1ml vial of Denub contains 60mg of Denosumab, along with other excipients that aid in its stability and delivery. The injection is administered subcutaneously, making it a convenient option for patients who may have difficulty with oral medications. Overall, Denub 60MG Injection is a vital therapeutic option for individuals at risk of fractures due to weakened bones.